Arkuda Therapeutics
PrivateLast Round
Series B
Feb 10, 2022
Total Funding Raised
$108M
Company Overview
Arkuda Therapeutics is a biotechnology company focused on developing neurodegenerative medicines aimed at altering the course of neurodegenerative diseases through innovative insights into progranulin and lysosomal biology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arkuda Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Arkuda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2022 | ||||
| Series A | Nov 7, 2019 |
Arkuda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Capital | Series A, Series B |
| Pivotal bioVenture Partners | Series B |
| Surveyor Capital | Series B |
| Nan Fung Group | Series B |
| Pfizer Ventures | Series B, Series A |
| Mission BioCapital | Series B |
| Atlas Venture | Series B, Series A |
Arkuda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arkuda Therapeutics's valuation, stock price, and market status.
